Neuroprotective Effects

This is a scientific guide.

Based on the latest medical studies.

  • know exactly how CBD helps protect the brain
  • discover the oral CBD dosages being tested and possible adverse effects
  • find out how this powerful nonintoxicating compound can benefit you

Let’s get started.

2020 CBD Research

Study will assess CBD benefits for quality of life, behavior symptoms and pain relief.

 

nih medical study

New CBD Study Published February 2019

cannabidiol study results graph

nih medical study

Our summary: 

  • This study will test the safety of a cannabis-based oil with a THC:CBD ratio of 3:2 (3 parts THC to 2 parts CBD).
  • The study will test CBD benefits for dementia by assessing effects on dementia behavior symptoms, quality of life and pain relief (1).

cannabidiol dementia benefits

Method: 

  • 18 week, randomized, double-blind crossover trial
  • 2-week eligibility period
  • two 6-week treatment cycles
  • two 2-week washout periods (2)

nih medical study

Participants: 

  • 50 participants with dementia
  • currently living in a residential care facility (3)

nih medical study

Evaluation:  Data will be collected on 7 occasions for the following assessments:

Download The Study

 

Check out this video about caring for the elderly with cannabinoids.

Study Authors:

Timler A

Institute for Health Research, University of Notre Dame Australia

Bulsara C

Institute for Health Research, University of Notre Dame Australia

Bulsara M

Institute for Health Research, University of Notre Dame Australia

Vickery A

Emerald Clinics, Perth

Smith J

Institute for Health Research, University of Notre Dame Australia

Codde J

 Institute for Health Research, University of Notre Dame Australia

 

Keywords: Behavioural and neuropsychiatric symptoms of dementia (BPSD); Crossover trial; Dementia; Medicinal cannabis; Pain; Quality of life

 

 References

Timler A, Bulsara C, Bulsara M, Vickery A, Smith J, Codde J. Use of cannabinoid-based medicine among older residential care recipients diagnosed with dementia: study protocol for a double-blind randomised crossover trial. Trials. 2020;21(1):188. Published 2020 Feb 14. doi:10.1186/s13063-020-4085-x

Pin It on Pinterest

Share This